Call Earnings Statistics: NeoGenomics, Inc. (NEO) Q4 2025
Management view
- CEO Anthony Zook announced record fourth-quarter 2025 revenues of $190 million, highlighting 11% year-over-year growth and stating, “Our clinical business continued strong growth, with revenues increasing 16% year-over-year.” He attributed the sturdy clinical effect
Alpha Search Disclaimer: This article was automatically generated by an AI tool from content available on Seeking Alpha and has not been curated or reviewed by humans. Due to the inherent limitations in the operate of AI-based tools, the accuracy, completeness or currency of such articles cannot be guaranteed. This article is for informational purposes only. Seeking Alpha does not take your goals or your financial situation into account and does not offer any personalized investment advice. Seeking Alpha is not a licensed U.S. securities dealer, broker-dealer, investment advisor or investment bank.
